(Q48208576)

English

Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

B G Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J S Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

C K Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J E Yeon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

M S Chang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J H Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

H Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

S Yi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J-Y Cho

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

S G Kim

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J-H Lee

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

0 references

publication date

22 February 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1073-1083

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

AGA technical review on nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Epidemiology of non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Endpoints and clinical trial design for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Therapeutic potential of dithiolethiones for hepatic diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Pharmacokinetics of Oltipraz and Its Major Metabolite (RM) in Patients With Liver Fibrosis or Cirrhosis: Relationship With Suppression of Circulating TGF-β1

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

An active metabolite of oltipraz (M2) increases mitochondrial fuel oxidation and inhibits lipogenesis in the liver by dually activating AMPK

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13981

21 January 2018

Identifiers

10.1111/APT.13981

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28225186%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48208576&oldid=1538921292"